Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
A randomized trial in 2022 revealed that Wegovy-treated patients experienced a significant 15.8% reduction in body weight compared to Saxendas 6.4% in a 68-week study
Related EMARKETER reports: Methodology: Data is from the Febraury 2025 Dentsu report titled "GLP-1s: Impact on Consumer Categories" conducted by Toluna
This diet focuses on foods that complement GLP-1 medications, enhancing their effectiveness in managing appetite and improving metabolism
Foods rich in fruits, vegetables, and whole grains provide key electrolytes necessary for bodily functions
21252128, 1995 [14] J
US$ 20.43
US$ 23.02
US$ 26.40
US$ 26.87
